These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21954055)

  • 1. Model-specific selection of molecular targets for heart failure gene therapy.
    Katz MG; Fargnoli AS; Tomasulo CE; Pritchette LA; Bridges CR
    J Gene Med; 2011 Oct; 13(10):573-86. PubMed ID: 21954055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting myocardial beta-adrenergic receptor signaling and calcium cycling for heart failure gene therapy.
    Pleger ST; Boucher M; Most P; Koch WJ
    J Card Fail; 2007 Jun; 13(5):401-14. PubMed ID: 17602988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene interventions in the beta-adrenergic system for treating heart failure.
    Parsa CJ; Koch WJ
    Semin Thorac Cardiovasc Surg; 2003 Jul; 15(3):259-67. PubMed ID: 12973703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential targets of gene therapy in the treatment of heart failure.
    Rosik J; Szostak B; Machaj F; Pawlik A
    Expert Opin Ther Targets; 2018 Sep; 22(9):811-816. PubMed ID: 30124081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic manipulation of beta-adrenergic signalling in heart failure.
    Davidson MJ; Koch WJ
    Acta Physiol Scand; 2001 Sep; 173(1):145-50. PubMed ID: 11678737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The myocardial beta-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats.
    Anderson KM; Eckhart AD; Willette RN; Koch WJ
    Hypertension; 1999 Jan; 33(1 Pt 2):402-7. PubMed ID: 9931137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic editing of dysfunctional myocardium.
    Hajjar RJ; Huq F; Matsui T; Rosenzweig A
    Med Clin North Am; 2003 Mar; 87(2):553-67. PubMed ID: 12693739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Effect of Cardiac Shock Wave Therapy on Myocardial Ischemia in Patients With Ischemic Heart Failure.
    Wang W; Liu H; Song M; Fang W; Yuan F
    J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):381-7. PubMed ID: 26657563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on gene therapy for myocardial ischaemia and left ventricular systolic dysfunction or heart failure.
    Roncalli J; Tongers J; Losordo DW
    Arch Cardiovasc Dis; 2010; 103(8-9):469-76. PubMed ID: 21074126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy targets in heart failure: the path to translation.
    Raake PW; Tscheschner H; Reinkober J; Ritterhoff J; Katus HA; Koch WJ; Most P
    Clin Pharmacol Ther; 2011 Oct; 90(4):542-53. PubMed ID: 21866097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy in heart failure.
    Vinge LE; Raake PW; Koch WJ
    Circ Res; 2008 Jun; 102(12):1458-70. PubMed ID: 18566312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GRK2 as a novel gene therapy target in heart failure.
    Rengo G; Lymperopoulos A; Leosco D; Koch WJ
    J Mol Cell Cardiol; 2011 May; 50(5):785-92. PubMed ID: 20800067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure.
    Rengo G; Lymperopoulos A; Zincarelli C; Donniacuo M; Soltys S; Rabinowitz JE; Koch WJ
    Circulation; 2009 Jan; 119(1):89-98. PubMed ID: 19103992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy for the treatment of heart failure--calcium signaling.
    Bernecker OY; del Monte F; Hajjar RJ
    Semin Thorac Cardiovasc Surg; 2003 Jul; 15(3):268-76. PubMed ID: 12973704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Adrenergic Receptor Signaling and Heart Failure: From Bench to Bedside.
    Bencivenga L; Liccardo D; Napolitano C; Visaggi L; Rengo G; Leosco D
    Heart Fail Clin; 2019 Jul; 15(3):409-419. PubMed ID: 31079699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and phenotypic targeting of beta-adrenergic signaling in heart failure.
    Koch WJ
    Mol Cell Biochem; 2004 Aug; 263(1-2):5-9. PubMed ID: 15524162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manipulation of beta-adrenergic receptor in pressure-overloaded murine hearts mimics adverse and reverse cardiac remodeling.
    Nishimura K; Asakura M; Hirotani S; Okuhara Y; Shirai M; Orihara Y; Matsumoto Y; Naito Y; Minamino N; Masuyama T; Ishihara M
    Biochem Biophys Res Commun; 2020 Jul; 527(4):960-967. PubMed ID: 32439165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic manipulation of myocardial beta-adrenergic receptor activation and desensitization.
    Hata JA; Williams ML; Koch WJ
    J Mol Cell Cardiol; 2004 Jul; 37(1):11-21. PubMed ID: 15242731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for heart failure.
    Thompson RB; Rungwerth K; Koch WJ
    Ann Med; 2004; 36 Suppl 1():106-15. PubMed ID: 15176432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism Gln27Glu of β2 Adrenergic Receptors in Patients with Ischaemic Cardiomyopathy.
    Metaxa S; Missouris C; Mavrogianni D; Miliou A; Oikonomou E; Toli E; Kormali L; Vlismas A; Drakakis P; Tousoulis D
    Curr Vasc Pharmacol; 2018; 16(6):618-623. PubMed ID: 28933308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.